fda glp-1 safety alert october 2025 How Crackdowns Are Affecting Use In The FDA has approved the

9 Semaglutide also resulted in significant improvements in secondary endpoints, including the 6-minute walk distance and weight loss

Our findings do not exclude a positive role for endosomal signaling or -arrestin-1 recruitment in acute responses to physiological GLP-1, but highlight how the kinetic context must be taken into account when exploiting noncanonical pathways during drug development

Access is still an issue for these effective medications. Clare Thompson, MD, a general practitioner who leads weight management services at the Cadogan Clinic in London, agrees

While these drugs can be very effective, the first week is often a time of adjustment as your body gets used to the medication